Explore Clinical Trials Arena – the leading website for the Industry!
Launched in August 2015, CTA is a free to read site catered to professionals involved in clinical trials, as well as the industry at large (pharma, biotech and medical devices). Drawing in over 1000 readers a week,CTA provides high quality content by delivering learning points and actionable information. As a reader, you will have access to articles covering a variety of aspects, from clinical operations and outsourcing to data management, and more.
Read articles written by fellow professionals who share their experiences working in an increasingly complex industry. Catch up on the latest interviews featuring industry executives from the likes of Merck and AstraZeneca where they discuss everything from risk-based monitoring to patient recruitment. Or keep up to date on upcoming Arena events.
Among our latest features, Antoine Freyss, Master Site Manager – IRT, Novartis (Switzerland) describes how IRT systems help clinical operations in a cost effective manner. With more and more trials taking place around the globe, the strain this has placed on the industry seems to know no bounds with a multitude of data being generated on a daily basis. In his article, Freyss explains how the use of IRT can streamline clinical trial processes.
Meanwhile, Marisa Piaggio, Clinical Project Manager, Galamed Pharmaceuticals (Argentina) provides an excellent overview on what companies should know when initiating trials in Latin America (LatAm). For sponsors looking to expand their presence abroad, Piaggio offers unique insight on her experiences starting up trials in an emerging market.
Regardless of which area you’re involved in, Clinical Trials Arena strives to deliver high quality content that impacts you from a global perspective. With over 50 percent of our articles written by industry professionals, CTA stands alone as the number one site for the industry about the industry.
Explore the website to discover more case studies of the key market challenges and opportunities and how these can be applied to your own trials.
Follow us on Twitter for the latest updates! @ArenaClinical